Radiation dose volume effects in radiation-induced rectal injury
J.M. Michalski, H. Gay, and A. Jackson Radiation dose volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S123 S129
Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose
W.G. Smit, P.A. Helle, and W.L.J. Van Putten Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose Int J Radiat Oncol Biol Phys 18 1990 23 29
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity modulated radiotherapy for localized prostate cancer
M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
Late rectal toxicity after 3D-conformal radiation therapy of prostate cancer: Multivariate analysis and dose-response
M. Skwarchuk, A. Jackson, and M. Zelefsky Late rectal toxicity after 3D-conformal radiation therapy of prostate cancer: Multivariate analysis and dose-response Int J Radiat Oncol Biol Phys 47 2000 103 113
Quantitative analyses of normal tissue effects in the clinic (QUANTEC): An introduction to the scientific issues
S.M. Bentzen, L.S. Constine, and J.O. Deasy Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 suppl3 2010 S3 S9
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
M.E. Charlson, P. Pompei, and K.L. Ales A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
Dose escalation for localized prostate cancer: Substantial benefit observed with 3D conformal therapy
Z. Symon, K.A. Griffith, and P.W. McLaughlin Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy Int J Radiat Oncol Biol Phys 57 2003 384 390
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
Normal tissue complication probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A test of the QUANTEC-recommended NTCP model
M. Liu, V. Moiseenko, and A. Agranovich Normal tissue complication probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: a test of the QUANTEC-recommended NTCP model Acta Oncologica 49 2010 1040 1044
Late rectal toxicity on RTOG 94-06: Analysis using a mixture Lyman model
S.L. Tucker, L. Dong, and W.R. Bosch Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model Int J Radiat Oncol Biol Phys 78 2010 1253 1260
Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06
S.L. Tucker, L. Dong, and J.M. Michalski Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06 Int J Radiat Oncol Biol Phys 84 2012 390 395
External beam radiotherapy for prostate cancer patients on anticoagulation therapy: How significant is the bleeding toxicity?
K.S. Choe, A.B. Jani, and S.L. Liauw External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity? Int J Radiat Oncol Biol Phys 76 2010 755 760